machine-learning-healthcare
(7)
The Chicago lab teaching hospitals to read your blood before sepsis reads you
Sepsis kills more Americans than all cancers combined and hides in plain sight. Prenosis spent a decade building a biobank and an algorithm to catch it in the first 24 hours - and got the FDA to say yes.
TachyHealth
TachyHealth is a UAE-based healthcare AI company that helps hospitals, clinics and insurers close the gap between clinical care and payment. Founded in 2018, it builds AI-driven tools for medical coding, claims review and auditing, and clinical decision support - branded AiCode, AiReview and AiGuide - aimed at reducing administrative burden, controllable revenue loss and claim denials while advancing value-based care across the Middle East and Africa. In October 2025 it raised a $5M Series A led by Saudi insurer Tawuniya.
Pathos AI
Pathos AI is an AI-driven biotech company building what it describes as one of the largest multimodal foundation models in oncology. By combining millions of clinical, molecular, and imaging records with proprietary AI, Pathos aims to identify the right patients for a given therapy, design smarter adaptive clinical trials, and de-risk cancer drug development. Founded in 2020 by Eric Lefkofsky and Ryan Fukushima and led since 2025 by CEO Iker Huerga, the company raised a $365 million Series D that valued it at roughly $1.6 billion.
Dimitrios Skaltsas
Dimitrios Skaltsas is the co-founder and CEO of Intelligencia AI, a New York enterprise software company that uses machine learning and curated biomedical data to estimate the probability that a drug candidate will win regulatory approval. Trained as a lawyer in Athens and London, he spent more than a decade at McKinsey, where he built and led New Ventures' big-data and AI work for pharmaceutical R&D before co-founding Intelligencia with Vangelis Vergetis in 2017. Under his leadership the company raised a Series A, was named one of Forbes's Top AI Companies to Watch, secured a U.S. patent for its probability-of-success assessments, and landed on the Inc. 5000. He is also an Executive in Residence at INSEAD.
Buoy Health
Buoy Health is a Boston-based digital health company that built an AI-powered symptom checker and care-navigation platform. Founded in 2014 out of Harvard Innovation Labs, Buoy lets people describe how they feel in a chat that mimics a conversation with a doctor, then steers them toward the right next step - from self-care at home to the ER - using an algorithm trained on thousands of medical studies. The company sells its navigation platform to employers, health plans and providers while keeping the consumer symptom checker free.
DermaSensor, Inc.
DermaSensor is a Miami-based medical device company that makes the first FDA-cleared, AI-powered handheld device for detecting all three common skin cancers - melanoma, basal cell carcinoma, and squamous cell carcinoma - at the point of care. Using elastic scattering spectroscopy and a machine learning algorithm trained on thousands of biopsy-confirmed lesions, the device gives primary care physicians a real-time, non-invasive read on whether a suspicious skin lesion warrants further evaluation, helping close the gap created by a shortage of dermatologists.
Garner Health
Garner Health is a New York-based healthcare technology company that analyzes billions of medical claims to identify the highest-performing doctors, then pairs that data with employer-funded financial incentives so employees can see top providers at a fraction of the out-of-pocket cost. Founded in 2019 by Nick Reber, the company combines a member-facing care navigation app and concierge with a provider analytics engine (Garner DataPro / Garner Research Agent) used by employers and health plans to cut healthcare spend while improving outcomes.